RELATED STUDY
I-FABP is decreased in COVID-19 patients, independently of the prognosis
Key Findings: This study found low levels of intestinal fatty acid-binding protein (I-FABP) in hospitalized patients with COVID-19 with or without gastrointestinal symptoms, and lower than in patients with non-COVID-19 pulmonary disease.
Type of Study: Clinical Trial
Study Sample Size: 28
Study Result: Positive
Research Location(s): France
Year of Pub: 2021
Cannabinoids Studied: Fatty Acid-Binding Protein (FABP)
Phytocannabinoid Source: Not Applicable
Citation: Guedj K, Uzzan M, Soudan D, Trichet C, Nicoletti A, Weiss E, Manceau H, Nuzzo A, Corcos O, Treton X, Peoc'h K. I-FABP is decreased in COVID-19 patients, independently of the prognosis. PLoS One. 2021 Apr 15;16(4):e0249799. doi: 10.1371/journal.pone.0249799. PMID: 33857216; PMCID: PMC8049236.
